These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32803216)

  • 1. Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.
    Huang J; Xie N; Hu X; Yan H; Ding J; Liu P; Ma H; Ruan L; Li G; He N; Wei S; Wang X
    Clin Infect Dis; 2021 Oct; 73(7):e2086-e2094. PubMed ID: 32803216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Coronavirus Disease 2019 in People Living With Human Immunodeficiency Virus in South Korea: A Nationwide Population-Based Cohort Study.
    Kim JY; Jeong Y; An H; Suh JW; Sohn JW; Yoon YK
    Influenza Other Respir Viruses; 2024 Jun; 18(6):e13337. PubMed ID: 38857604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series.
    Hu Y; Ma J; Huang H; Vermund SH
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):1-5. PubMed ID: 32568771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.
    Wu M; Ming F; Wu S; Liu Y; Zhang X; Guo W; Marley G; Tang W; Liang K
    Front Public Health; 2022; 10():833783. PubMed ID: 35570882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. People living with HIV easily lose their immune response to SARS-CoV-2: result from a cohort of COVID-19 cases in Wuhan, China.
    Liu Y; Xiao Y; Wu S; Marley G; Ming F; Wang X; Wu M; Feng L; Tang W; Liang K
    BMC Infect Dis; 2021 Oct; 21(1):1029. PubMed ID: 34598701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.
    Wu S; Ming F; Xing Z; Zhang Z; Zhu S; Guo W; Zou S; Liu J; Liu Y; Liang K
    Front Public Health; 2022; 10():883453. PubMed ID: 35615040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
    Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
    HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave.
    Snyman J; Hwa SH; Krause R; Muema D; Reddy T; Ganga Y; Karim F; Leslie A; Sigal A; Ndung'u T;
    Clin Infect Dis; 2022 Aug; 75(1):e249-e256. PubMed ID: 34472583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
    Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
    D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
    HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving force of COVID-19 among people living with HIV in Wuhan, China.
    Guo W; Ming F; Dong Y; Zhang Q; Liu L; Gao M; Zhang X; Mo P; Feng Y; Tang W; Liang K
    AIDS Care; 2022 Nov; 34(11):1364-1371. PubMed ID: 35319336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.
    Meiring S; Tempia S; Bhiman JN; Buys A; Kleynhans J; Makhasi M; McMorrow M; Moyes J; Quan V; Walaza S; du Plessis M; Wolter N; von Gottberg A; Cohen C;
    Clin Infect Dis; 2022 Aug; 75(1):e144-e156. PubMed ID: 35134129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.
    Sigel K; Swartz T; Golden E; Paranjpe I; Somani S; Richter F; De Freitas JK; Miotto R; Zhao S; Polak P; Mutetwa T; Factor S; Mehandru S; Mullen M; Cossarini F; Bottinger E; Fayad Z; Merad M; Gnjatic S; Aberg J; Charney A; Nadkarni G; Glicksberg BS
    Clin Infect Dis; 2020 Dec; 71(11):2933-2938. PubMed ID: 32594164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV.
    Meyerowitz EA; Kim AY; Ard KL; Basgoz N; Chu JT; Hurtado RM; Lee CK; He W; Minukas T; Nelson S; Ojikutu BO; Robbins G; Sanchez S; Triant VA; Zachary K; Gandhi RT
    AIDS; 2020 Oct; 34(12):1781-1787. PubMed ID: 32604138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1.
    Levy I; Wieder-Finesod A; Litchevsky V; Biber A; Indenbaum V; Olmer L; Huppert A; Mor O; Goldstein M; Levin EG; Hod T; Cohen C; Lustig Y; Rahav G
    Clin Microbiol Infect; 2021 Dec; 27(12):1851-1855. PubMed ID: 34438069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.
    Lian J; Jin X; Hao S; Jia H; Cai H; Zhang X; Hu J; Zheng L; Wang X; Zhang S; Ye C; Jin C; Yu G; Gu J; Lu Y; Yu X; Xiang D; Li L; Liang T; Sheng J; Yang Y
    Influenza Other Respir Viruses; 2020 Sep; 14(5):564-574. PubMed ID: 32397011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.
    Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E; de la Mora L; Martinez-Rebollar M; Laguno M; Callau P; Gonzalez-Navarro A; Leal L; Garcia F; Mallolas J; Mosquera M; Marcos MA; Ambrosioni J; Miro JM; Martinez E; Blanco JL;
    AIDS; 2020 Oct; 34(12):1775-1780. PubMed ID: 32773471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.